Essential Hypertension (EH) is a complex disorder resulting from the interplay of various genetic and environmental risk factors. Despite extensive efforts in the field, the underlying pathways leading to this complex phenotype remain elusive. However, during the past two decades, genetic studies including both the single point and haplotype associations investigating the components of important physiological blood pressure control systems have provided important insights into understanding EH. In this respect, the study of adrenergic receptors has been of great importance as their interaction with catecholamines plays an important role in influencing the control of vasomotion and regulating the metabolism of lipids, proteins and carbohydrates as well. 1, 2 Several polymorphisms in the adrenergic b 1 and b 2 receptor genes have been found to be associated with EH, BMI and diabetes mellitus. 3 In a previous issue of this journal, Wallerstedt et al. 4 investigated the association of two polymorphisms in the adrenergic b 2 receptor in patients with MI and found a particular haplotype to be associated with an increased risk of EH. As indicated earlier, their findings are not unique as the gene has previously been shown to be associated with EH. 1, 3 However, the haplotype analyses as detailed in the study do not appear to have been conducted according to an appropriate method.
Haplotype analyses are performed in multiple steps. 5, 6 Initially, the polymorphisms in a gene are investigated for any nonrandom association of alleles at linked loci. This is defined as linkage disequilibrium (LD), and usually expressed as D, D 0 or r 2 . Polymorphisms found to be in LD are further investigated using different statistical methods for inferring haplotypes using genotypic data in unrelated individuals. Most of these methods rely on expectation-maximization (EM) and Newton-Raphson (NR) algorithms. The inferred haplotype frequencies can then be used as weights in a regression model, upon which haplotype-based associations with disease outcome may be inferred. These regression models are usually drawn and analysed using different computer softwares. 5, 6 Regarding the study in question, the authors have failed to report any LD between the polymorphisms. Understandably, a lack of LD among the SNPs would preclude any useful inference derived from their additive analysis. Moreover, the authors have failed to report the algorithm used to derive the haplotype frequencies. Without this information, any conclusions made regarding haplotype interaction and outcome of EH based on the findings of this study would be incomplete.
Many studies performed on complex disorders have found haplotypes that explain the risk of disease more so than individual SNP's. 5, 7 Association studies looking at the association of individual SNP's with a disease may fail to appreciate information attributed to biallelic polymorphisms and may suffer from an inflated type-I error compounded from serial comparisons. 2 This may be avoided through analysis of a combination of sites on specific alleles (phases on chromosomes) in association with the disease. The premium example is the study performed by Drysdale et al. 5 Drysdale et al. 5 correlated an individual's genetic response to salbutamol with the interaction of multiple SNPs within a haplotype, but found no such correlation with the individual SNPs.
In conclusion, the shortcomings outlined above would have to be addressed before any meaningful conclusions about interactions among SNPs could be drawn from the study performed by Wallerstedt et al.
